JP2017105539A - Medicine container - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide a medicine container capable of efficiently volatilizing a medicine and of preventing contamination of peripheral members in a container installation site.SOLUTION: In a medicine container of the present invention, a container body 1 comprises a bottom face 23, a side face, and a top face 13, and the vaporization holes 14 are formed on the portions other than the bottom face 23. The distance between the surface of a carrier 4 and the vaporization hole 14 is retained in the range from 0.5 to 60 mm in such a state that the medicine-retaining carrier 4 is placed on the bottom face 23. Besides, there is formed a protrusion capable of retaining an interval of 2 mm or more between a virtual plane circumscribed to a proper place adjacent to the vaporization hole 14 and the opening edge of a container outside of the vaporization hole 14.SELECTED DRAWING: Figure 6

Description

  The present invention relates to a drug container for storing a volatile drug or a sublimation drug such as an insect repellent, an insecticide, a fragrance, a deodorant, or a bactericide and volatilizing a volatile component of the drug in a room. .

  A carrier that has been held in an appropriate shape by impregnating it with a volatile drug, or a solidified product that has been molded into an appropriate shape with a sublimable drug, placed in an appropriate place in the room while housed inside, A drug container configured to obtain the efficacy of a drug over a certain period by volatilizing a volatile component or sublimation component of the drug in the air from a plurality of volatilization holes formed in the container body is known.

  As an example of such a drug container, Patent Document 1 discloses a drug container in which a container body has a flat rectangular parallelepiped shape, and volatilization holes are formed on both opposing main surface portions (the widest two of the six surfaces). Has been. Further, Patent Document 2 discloses a drug container in which a container body has a long and narrow rectangular tube shape, and a large number of thin slit-like volatilization holes are formed on three of the four peripheral walls surrounding the long axis. Yes.

JP 2014-111474 A JP 2012-25431 A

  In this type of drug container, it is desirable that a volatile component and a sublimation component of the drug are stably volatilized in a predetermined amount over a predetermined period in a room in which the container is installed. Such control of the volatilization amount has been conventionally performed by appropriately adjusting the size and shape of the carrier, the component and concentration of the drug, the shape and open area of the volatilization hole, and the like.

  However, there is no prior art document that attempts to optimize the volatilization amount by paying attention to the distance between the carrier holding the drug or the solidified drug and the volatilization hole formed in the container body. Accordingly, the present invention provides a first solution to efficiently and stably volatilize the volatile component and sublimation component of the drug by appropriately adjusting the distance between the surface of the solidified substance of the carrier or drug and the volatilization hole. It is said.

  In addition, among the chemicals that use this type of chemical container, the volatile components and sublimation components are the components around the installation site (wood, sheet material, decorative board, paint, etc. that constitute the surface of crops, storage furniture, etc. Some of them tend to discolor or deform the member or adsorb odor to the member (for example, mint oil, rosemary oil, etc.) . When such a chemical | medical agent is accommodated in a container with high volatilization efficiency, there exists a possibility of having a bad influence with respect to the surrounding member of an installation place.

  Therefore, the present invention prevents the influence of the agent from fouling the surrounding members of the installation place by securing a preferable interval between the volatilization hole formed in the container body and the surrounding members of the installation place. Is the second problem to be solved. In particular, with regard to this issue, consideration should be given to the situation where the main body of the container falls from the normal installation state for some reason, and the volatilization hole that is originally facing upward is in close contact with the installation surface. To do.

  In order to solve the above-mentioned problems, the present invention comprises a solidified material such as a carrier or a sublimable chemical that holds a volatile drug, and a container main body that accommodates the carrier or the solidified material. The main body is formed with a volatilization hole for communicating the inside and outside of the main body of the container to volatilize the medicine, and the main body of the container is appropriately placed in a state where the carrier or the solidified material is placed. A bottom surface portion, a side surface portion and a top surface portion continuous to the bottom surface portion, and the volatilization hole is formed in a portion other than the bottom surface portion in the container body, and the carrier or the In a state where the solidified product is placed, the distance between the surface of the carrier or the solidified product and the volatilization hole is maintained within a range of 0.5 to 60 mm, and in a suitable position close to the volatilization hole, A virtual plane circumscribing the right place The convex portion of the at least one position capable of holding more gap 2mm between the container outer opening edge of the volatilization holes are formed, employing the basic configuration of the.

  Adopting such a configuration, the surface of the carrier or solidified product and the volatilization hole are separated from each other by a predetermined distance, whereby the volatile component of the drug is efficiently volatilized out of the container through the volatilization hole formed in the container body. be able to. In addition, the convex portion formed on the outer side of the container body prevents the opening edge of the volatilization hole from coming into contact with the surrounding members of the installation place, and maintains a preferable gap between the volatilization hole and the surrounding members. Even when the installation posture of the container main body is changed, the surrounding members are prevented from being soiled by the volatile component of the medicine.

  And this invention employ | adopts the structure that the said convex part was provided in the multiple places of the said top | upper surface part of the said container main body as a specific aspect of the container main body based on the above-mentioned basic structure.

  Further, as another specific aspect of the container main body based on the basic configuration described above, the top surface portion of the container main body is formed in a shape that is an upward convex surface as a whole, and the top portion of the top surface portion is the convex portion. Adopted the configuration with.

  If the container body has these shapes, when the container body is turned upside down, the convex part provided on the top surface part comes into contact with the installation surface, and the surrounding area will be lifted from the installation surface, so it is formed on the top surface part. It is easy to secure a predetermined gap between the volatilization hole and the installation surface.

  Further, with respect to the container main body formed in a shape in which the top surface portion is an upward convex surface as a whole, the top surface portion is provided with a recessed portion that is lower than the upward convex surface so as not to reach the zenith portion. The volatilization hole may be formed in the recess.

  In addition, a pedestal portion on which the back surface of the carrier or the solidified product can be floated by 0.5 mm or more from the top surface of the bottom surface portion may be formed on the bottom surface portion.

  In addition, a pressing projection that protrudes downward to the vicinity of the surface of the carrier or the solidified material placed on the bottom surface portion may be formed on the back surface of the top surface portion.

  According to the drug container of the present invention configured as described above, a suitable air movement occurs in the internal space of the container body by separating the surface of the carrier and the volatilization hole by a predetermined distance, and the carrier is held by the carrier. The volatile components of the squeezed drug are efficiently volatilized out of the container through the volatilization holes formed in the container body.

  Further, on the outside of the container main body, a convex portion is formed to prevent the opening edge of the volatilization hole outside the container from coming into contact with the surrounding members of the installation place, and at least between the volatilization hole and the surrounding members. Since the gap of 2 mm is maintained, it is possible to prevent the surrounding members from being soiled by the volatile components of the drug, no matter how the installation posture of the container body changes.

It is a graph of the experimental result which backs up the effect of this invention. It is another graph of the experimental result which backs up the effect of this invention. It is a perspective view of the chemical | medical agent container which concerns on embodiment of this invention. It is a disassembled perspective view of the said medicine container. It is a top view (cum section position guide diagram) of the medicine container. It is AA sectional drawing of the said chemical | medical agent container. It is BB sectional drawing of the said chemical | medical agent container. It is CC sectional drawing of the said chemical | medical agent container. It is DD sectional drawing of the said chemical | medical agent container. It is AA sectional drawing in the state where the said medicine container was turned over. It is a schematic perspective view of the chemical | medical agent container which concerns on other embodiment of this invention. It is a schematic perspective view of the chemical | medical agent container which concerns on other embodiment.

(Basic configuration of the present invention)
First, the present invention comprises a solidified material such as a carrier that holds a volatile drug or a sublimable chemical, and a container main body that stores the carrier or the solidified chemical, and the container main body includes the container main body. It is assumed that this is a drug container in which a volatilization hole for communicating the inside and outside of the gas and volatilizing the drug is formed.

  Here, as a volatile chemical | medical agent, various conventionally well-known various insect repellents which have volatility or sublimation property, an insecticide, an aromatic agent, a deodorizing agent, a disinfectant, etc. are included. Insect repellents and insecticides include clothing pests such as moths, oysters and cutworms, mosquitoes such as mosquitoes, chikaeka, shrimp mosquitoes, and mosquitoes such as house flies, fly flies, clover flies, mosquito flies, fly flies, fly flies, etc. Flying insects such as butterflies such as giant butterflies and shrimp flies, chironomids such as sesame chironomid and chimney chironomid, mosses such as Noshimemadera, sanitary pests such as cockroaches and indoor dust mites, storage pests such as wolfberry, aphids As an agent that can exhibit high insecticidal and insecticidal effects on various pests such as planthoppers, stink bugs, and centipedes, for example, pyrethroid insecticides such as empentrin, profluthrin, transfluthrin, cypress oil, hiba oil, mint oil, spearmint Oil, me Di oil, lemon oil, chamomile oil, eucalyptus oil, lavender oil, bergamot oil, other natural essential insect repellents, paramenttan-3,8 diol and other various kinds of natural oils, including single compounds that are naturally present in essential oils Insect repellents and insecticides can be applied. In addition, as the bactericidal agent, chlorine-based bactericidal agents such as IPMP, PCMX, iodine, AIT, and ClO 2 can be applied.

  And as a carrier for holding these drugs, for example, paper, twisted yarn, non-woven fabric, wood, pulp, porous ceramic, synthetic resin foam, and other fixed forms by means such as impregnation, coating, kneading, etc. Various conventionally known materials that can be fixed to the surface can be appropriately used depending on the kind of the drug. Further, the drug can be gelled and held with agar, carrageenan, 12-hydroxystearic acid or the like. Furthermore, water absorption such as polyacrylate, polysulfonate, maleic anhydride, polyacrylamide, polyvinyl alcohol, polyethylene oxide, polyglutamate, polyalginate, starch, and cellulose It can also be held in an oil-absorbing resin such as a resin or a thermoplastic synthetic rubber copolymer. The shape of the carrier is arbitrary as long as it has a surface area that does not hinder the natural volatilization of the drug. For example, a thin plate shape, a refracted sheet shape, a mesh shape, a lattice shape, a large number of granular materials are put in a net bag. The shape can be adopted.

  In addition, solidified sublimable substances such as paradichlorobenzene, naphthalene, camphor, etc., silicic anhydride tablets, and solidified products in which the drug itself is molded into a certain shape, such as drug-permeable films In the present invention, it can be handled in the same manner as the above-mentioned carrier. Therefore, in the following description, the carrier holding the volatile drug and the solidified product such as the sublimable drug are collectively referred to as “carrier etc.”.

  And this invention, The said container main body is equipped with the bottom face part installed in a suitable installation place in the state which mounted | wore the said support | carrier, etc., The side part and the top | upper surface part which continue to the said bottom face part, The said volatilization hole Is formed in a portion other than the bottom surface portion of the container body, and the distance between the surface of the carrier and the volatilization hole is 0.5 to 60 mm in a state where the carrier is placed on the bottom surface portion. A convex portion that is held within a range and can hold a gap of 2 mm or more between a virtual plane circumscribing the proper location and an opening edge outside the vessel of the volatilization hole is provided at a proper location close to the volatilization hole. The basic structure is adopted.

  This basic configuration is that when the distance between the surface of the carrier or the like housed in the container body and the volatilization hole formed in the container body is kept in the range of 0.5 to 60 mm, the volatile component of the drug is volatilized out of the container particularly efficiently. It was obtained by the new knowledge that The experimental results that serve as the basis for this finding are shown in FIGS.

The present applicant prepared a plurality of impregnated mint oil 400 mg as a repellent on a carrier made of pulp fiber, and placed them in a synthetic resin experimental container in which a volatilization hole of 100 mm ² was formed on the top surface portion. Of the carrier. Then, the distance from the carrier to the opening edge inside the container of the volatilization hole is set in nine ways (0 mm, 1 mm, 2 mm, 7 mm, 12 mm, 17 mm, 37 mm, 47 mm, 77 mm) in the range of 0 to 77 mm, and each experimental container Was placed in a measurement box with a volume of about 20 L, and the cumulative volatilization amount of mint oil volatilized from each carrier was measured over about 24 days under the condition of 25 ° C.

  In Fig. 1, the horizontal axis represents the number of days elapsed from the start of the experiment, and the vertical axis represents the total volatilization amount for each of the nine settings with different distances from the carrier to the volatilization holes. It is a graph showing change of. In FIG. 2, the horizontal axis represents the distance from the carrier to the volatilization hole, and the vertical axis represents the total volatilization amount on the 11th day and the 23rd day in nine settings with the distance changed, It is a graph showing the correlation between distance and volatilization efficiency.

  In this experiment, when the distance from the carrier to the volatilization hole was 7 mm, the cumulative volatilization amount became maximum throughout the entire period. Hereinafter, the cumulative volatilization amount gradually decreased in the order of 12 mm, 17 mm or 2 mm, 1 mm, 37 mm, 47 mm, and 77 mm. When the distance was 0 mm, the cumulative volatilization amount became the minimum over almost the entire period. The reason why the volatilization efficiency became the lowest at 0 mm is considered to be that the carrier can block the opening of the volatilization hole, so that it can be volatilized only from the range substantially corresponding to the opening area of the volatilization hole. Therefore, it is preferable to provide a space through which air flows in the lateral direction (direction perpendicular to the direction of communication of the volatilization holes) even slightly between the surface of the carrier and the volatilization holes. The space is preferably at least 0.5 mm, and practically 1 mm or more.

  On the other hand, if the carrier and the volatilization hole are separated from each other by a certain degree or more, the volatilization efficiency is gradually decreased according to the distance. Therefore, the distance between the carrier and the volatilization hole is preferably within 60 mm, and practically within 40 mm.

  And if the volatilization efficiency of a chemical | medical agent increases by such a structure, it will be necessary to consider further also about the possibility that the volatile component of a chemical | medical agent may contaminate the surrounding member of an installation place. Therefore, in the present invention, the volatilization hole is formed in the other part (at least a part of the side part or the top part) avoiding the bottom part of the container body. Thereby, if it is a normal use state, the situation where the volatile component of a chemical | medical agent stains the mounting surface of a container can be prevented.

  However, due to some unforeseen circumstances, the container may fall, invert, or tilt, and the portion provided with the volatilization hole may come into contact with the installation surface or the peripheral wall surface of the installation site. Therefore, in the present invention, a convex portion capable of holding a gap of 2 mm or more is formed in the vicinity of the volatilization hole between the virtual plane circumscribing the vicinity and the opening edge of the volatilization hole outside the container. By providing such a convex portion in the vicinity of the volatilization hole, even when the installation posture of the container body changes unnaturally, a gap of at least 2 mm is always ensured between the volatilization hole and the installation surface or peripheral wall surface. be able to.

  The reason why the distance from the surroundings is 2 mm or more depends on the following experiment. That is, a carrier impregnated with mint oil is prepared in the same manner as in the experiment described above, and stored in a container, and three types of other members (urethane, styrene, lacquer) are placed at a position 0 to 3 mm away from the volatilization hole of the container. After installation, the progress was observed for 7 days in an environment of 40 ° C. The observation results are shown in Table 1.

  Thus, when all three types of members were placed in contact with the volatilization holes (0 mm), clear deformation / discoloration was observed (×). Even when the distance to the volatilization hole was 1 mm, slight deformation / discoloration was confirmed in all the members (Δ). However, when the distance from the volatilization hole was 2 mm or more, none of the members was deformed or discolored (◯). In the present invention, based on this experimental result, the size of the gap preferably secured between the volatilization hole and the installation surface or the peripheral wall surface is set to “2 mm or more”.

(Embodiment)
Embodiments of the present invention embodying the basic configuration described above will be described with reference to the drawings.

  3 to 10 show a drug container according to an embodiment of the present invention. The drug container includes a carrier 4 that holds a volatile drug and a container body 1 that stores the carrier 4. The container body 1 is formed of a synthetic resin material such as polyethylene terephthalate, which is lightweight, inexpensive, has an appropriate mechanical strength, and has excellent corrosion resistance and antifouling properties against volatile chemicals. The container lower half 20 on which the container is placed and the container upper half 10 covered in a lid shape are combined in a separable manner.

  The illustrated container lower half 20 includes a generally flat bottom surface portion 23 having a substantially rectangular planar shape, lower half side surface portions 21 and 22 standing at a uniform height from the four circumferences thereof, and a lower side on the long side. It has four engagement pieces 24 that rise from the vicinity of both ends to the upper side of the lower half side surface portion 22 along the inner side surface of the half side surface portion 22. Each engagement piece 24 is formed with a locking groove 25 extending in the lateral direction. In addition, a pedestal portion 26 having a circular shape in plan view is formed in the approximate center of the upper surface of the bottom surface portion 23.

  The illustrated container upper half 10 includes a top surface portion 13 having a plane shape substantially the same as the bottom surface portion 23, and upper half side surface portions 11 and 12 that hang down at a uniform height from the four circumferences thereof. The top surface portion 13 is formed so that its upper surface forms a gentle convex surface that is generally upward. Also, horizontally long locking claws 16 that can be locked in the locking grooves 25 of the container lower half 20 are formed in the vicinity of both ends of the upper half side surface portion 12 on the long side.

  When this container upper half 10 is overlapped with the container lower half 20 and each locking claw 16 is engaged with each locking groove 25, the lower half side surface portions 21, 22 and the upper half side surface portions 11, 12 are mutually connected. And the engagement piece 24 supports the top surface portion 13 by bringing the upper edge of the engagement piece 24 into contact with the back surface of the top surface portion 13 and is flat and hollow as a whole. A kamaboko-shaped container body 1 is obtained. In addition, the design dimensions of the illustrated container body 1 are, for example, long side 55 mm × short side 47 mm × height 15 mm.

  The top surface portion 13 is formed with a recessed portion 17 that is one step lower than the top surface of the top surface portion 13. The recessed portion 17 has a leaf-shaped planar shape surrounded by a pair of congruent arcs that protrude in opposite directions, and is shallow in a plan view formed in the center (the zenith portion) of the top surface portion 13. It is arranged at four locations so as to have a substantially X-shaped radial shape across the recess. As shown in FIG. 9, the inner bottom surface of the recessed portion 17 is a plane in which the majority region near the zenith portion is substantially horizontal, and a portion of the region near the short side of the container body 1 is inclined slightly downward toward the short side. It has become.

  Seven volatilization holes 14 each having a circular shape in plan view are formed on the inner bottom surface of each recess 17 so as to communicate the inside and outside of the container body 1 in the vertical direction. The diameter of the illustrated volatilization hole 14 is about 2 mm. In addition, three volatilization holes 14 are formed on the long axis of the top surface portion 13 (a line passing through the zenith portion in parallel with the long side of the container body 1) near both short sides. . Formed along a circular depression formed at one position on the shortest side of the inner bottom surface of each recessed portion 17 and a short axis of the top surface portion 13 (a line passing through the zenith portion parallel to the short side of the container body 1). The three depressions on both sides are dummy decorative holes 18 that do not penetrate the top surface portion 13 in the vertical direction.

  In addition, on the back surface of the top surface portion 13, a presser protrusion 15 is formed that hangs down so as to partition the inner upper portion of the container body 1 along the short axis.

  The state in which the carrier 4 is housed inside the container body 1 will be described with reference to the cross-sectional views of FIGS.

  The carrier 4 held by impregnating the medicine is taken out from an appropriate protective wrapping material (not shown) or the like and placed on the bottom surface portion 23 of the container lower half 20. In the present invention, the shape and material of the protective packaging material are not particularly limited. The illustrated carrier 4 is formed in a thin plate shape having a rectangular shape in plan view, and the thickness thereof is approximately half or less of the maximum height of the internal space of the container body 1. The design dimensions of the illustrated carrier 4 are, for example, 41 mm long side × 22 mm short side × 3 mm thickness.

  The carrier 4 is placed horizontally on the pedestal portion 26 in a posture in which the long side is parallel to the long side of the container body 1. Here, the pedestal portion 26 is formed to have a height of at least 0.5 mm, whereby the back surface of the carrier 4 is placed in a state of being lifted by 0.5 mm or more from the upper surface of the bottom surface portion 23. Thus, if a gap is provided between the back surface of the carrier 4 and the bottom surface portion 23 of the container main body 1, volatilization from the back surface side of the carrier 4 is promoted, and the volatilization efficiency as a whole is improved. Note that the shape, number, arrangement, and the like of the pedestal portion 26 can be appropriately set according to the shape of the carrier 4.

  On the other hand, a distance of 3 mm to 7 mm is secured between the surface of the carrier 4 and the opening edge inside the container of the volatilization hole 14 depending on the part. By exposing a part of the front surface, side surface and back surface of the carrier 4 to the internal space of the container body 1 formed in this way, the medicine held on the carrier 4 is efficiently volatilized into the internal space of the container body 1, It rides on the flow of air entering and exiting the volatilization hole 14 and diffuses outward from the container body 1.

  FIG. 10 shows a state in which the medicine container is turned over by receiving some external force. In this state, the zenith portion of the top surface portion 13 that forms a gentle convex surface as a whole comes into contact with the installation surface 5, and the peripheral portion of the top surface portion 13 is held in a posture that is lifted from the installation surface 5. In addition, since the volatilization hole 14 is not formed in the zenith part of the top | upper surface part 13, the volatilization hole 14 does not contact | abut the installation surface 5. FIG.

  In this way, the recessed portion 17 provided slightly apart from the zenith portion is held in a state where it does not contact the installation surface 5, so that the volatilization hole 14 formed on the inner bottom surface of the recessed portion 17 and the installation surface 5 A gap of about 2 mm corresponding to the depth of the recessed portion 17 is ensured between the two.

  In addition, since the four recessed portions 17 are formed at positions that are radial in plan view with the zenith portion of the top surface portion 13 as the center, the center of gravity of the container body 1 is held near the center of the plane, and the container body Even when 1 is turned over, its posture is easily stabilized.

  Further, in this state, the carrier 4 is supported from below by a pressing protrusion 15 formed on the back surface of the top surface portion 13 and is held near the upper portion of the internal space of the container body 1. Therefore, the volatilization hole 14 formed in the top surface portion 13 is not blocked by the carrier 4 falling to the top surface side, and a suitable volatilization state of the medicine is maintained. The shape, number and arrangement of the presser protrusions 15 and the degree of approach to the surface of the carrier 4 can be set as appropriate according to the shape of the carrier 4 and the cross-sectional shape of the container body 1.

  In this way, it has a flat proportion whose height is relatively smaller than the width of the bottom surface, and the top surface portion 13 is formed in a kamaboko shape or dome shape having a substantially arched vertical cross section, and at the zenith portion If the carrier 4 is housed in the container body 1 having a shape in which the volatilization hole 14 is not formed and the zenith portion protrudes or bulges outward from the volatilization hole 14 adjacent to the zenith portion, the top surface portion 13 Even if the curvature of the convex surface is small, it becomes easy to secure a predetermined gap between the volatilization hole 14 near the zenith portion and the installation surface 5, and as a result, the volatile component of the medicine is prevented from fouling the installation surface 5. can do.

(Other embodiments)
The present invention is not limited to the above-described embodiment, and can be implemented by variously modifying the shape or the like of the container body 1. That is, the volatilization hole 14 is formed in a portion other than the bottom surface part 23 of the container main body 1, and a predetermined distance is secured between the surface of the carrier 4 accommodated in the container main body 1 and the opening edge inside the container of the volatilization hole 14. Furthermore, as long as it has a convex portion that can hold a predetermined gap between a virtual plane circumscribing the proper position and the opening edge outside the container of the volatilization hole 14 at an appropriate position close to the volatilization hole 14, The planar shape, cross-sectional shape, dimensions and thickness of each part of the container body 1, the division / engagement form of the container upper half 10 and the container lower half 20, the position, the number, and the opening shape of the volatilization holes 14 are arbitrary. . Further, the shape, height, arrangement and the like of the presser protrusion 15 formed on the back surface of the pedestal portion 26 and the top surface portion 13 on which the carrier 4 is placed are arbitrary as long as the practicality of the medicine container is not impaired.

  Here, the “appropriate location close to the volatilization hole 14” of the container body 1 means that when the container body 1 having various shapes is in various postures by overturning or reversing, the installation surface of the installation place in that state. 5 or a portion that contacts the side wall surface or the like, and the “virtual plane circumscribing the appropriate position” assumes the installation surface 5 or the side wall surface in that state. In order to hold the volatilization hole 14 away from the installation surface 5 or the side wall surface in this state, an appropriately shaped portion formed so as to protrude or bulge outward from the container body 1 is referred to as a “convex portion”. And collectively. The volatilization hole 14 is not formed in this convex part. In the above-described embodiment, the zenith portion of the top surface portion 13 corresponds to the convex portion.

  11 and 12 show examples of various container bodies according to other embodiments of the present invention. The container body 1 shown in FIGS. 11A to 11F has a substantially rectangular planar shape as a whole, and is divided and coupled in the vertical direction. And in (a), the volatilization hole 14 is formed in the center vicinity of the top | upper surface part 13, and the convex part 19 is protrudingly provided by the four corners of the top | upper surface part 13. FIG. In (b), the top surface portion 13 is formed in a mountain-valley shape, and the elongated volatilization hole 14 is formed along the valley portion, so that the mountain portion becomes the convex portion 19. In (c), an elongated volatilization hole 14 is formed near the center of the top surface portion 13, and a convex portion 19 is raised along the long side of the top surface portion 13. In (d), the top surface portion 13 of (c) is an upward concave surface as a whole, and the long side portion is a convex portion 19. In (e) and (f), a convex portion 19 having an appropriate shape protrudes from the central portion of the top surface portion 13, and a volatilization hole 14 is disposed near the periphery of the convex portion 19.

  The container body 1 shown in FIG. 12 (g) has a substantially circular shape when viewed from above, and has a dome shape in which the entire top surface portion 13 swells into a spherical shape, and the volatilization holes 14 are radially spaced from the zenith portion. The zenith portion is a convex portion 19 corresponding to the volatilization hole 14. (H) is the one in which a higher tower-like convex portion 19 is protruded from the zenith portion of the container body 1 of (g). The container main body 1 of (i) has a cylindrical shape as a whole, and the volatilization holes 14 are arranged along the inner peripheral surface of the circular hole formed in the central portion thereof. In this example, the entire cylindrical outer peripheral surface and the upper and lower circular end surfaces correspond to the convex portion 19.

  Thus, the present invention can be applied to container bodies having various shapes.

DESCRIPTION OF SYMBOLS 1 ... Container main body 10 ... Container upper half body 11 ... Upper half side surface part 12 ... Upper half side surface part 13 ... Top surface part 14 ... Volatilization hole 15 ... Pressing protrusion 16 ... Locking claw 17 ... Recessed part 18 ... Dummy decoration hole 19 ... convex part 20 ... container lower half 21 ... lower half side part 22 ... lower half side part 23 ... bottom part 24 ... engagement piece 25 ... locking groove 26 ... pedestal part 4 ... carrier 5 ... installation surface

Claims (6)

A solidified substance such as a carrier holding a volatile drug or a sublimable drug;
A container main body for storing the carrier or the solidified product,
In the container body, in a drug container formed with a volatilization hole for communicating the inside and outside of the container body to volatilize the drug,
The container body includes a bottom surface portion installed at an appropriate installation location in a state where the carrier or the solidified material is placed, and a side surface portion and a top surface portion continuous with the bottom surface portion,
The volatilization hole is formed in a portion other than the bottom surface portion in the container body,
While the carrier or the solidified material is placed on the bottom surface, the distance between the surface of the carrier or the solidified material and the volatilization hole is maintained within a range of 0.5 to 60 mm,
At an appropriate place close to the volatilization hole, at least one convex portion capable of holding a gap of 2 mm or more was formed between a virtual plane circumscribing the appropriate position and an opening edge outside the container of the volatilization hole. A drug container characterized by. The drug container according to claim 1, wherein
The said convex part was provided in the multiple places of the said top | upper surface part of the said container main body, The medicine container characterized by the above-mentioned. The drug container according to claim 1, wherein
The drug container, wherein the top surface portion of the container body is formed into a shape having a convex surface as a whole, and the zenith portion of the top surface portion is the convex portion. The medicine container according to claim 3,
The top surface portion of the container body is provided with a recessed portion that is lower than the upward convex surface so as not to reach the top portion, and the volatilization hole is formed in the recessed portion. Drug container. In the medicine container given in any 1 paragraph of Claims 1-4,
The drug container, wherein a pedestal portion on which the back surface of the carrier or the solidified product is floated by 0.5 mm or more from the top surface of the bottom surface portion is formed on the bottom surface portion. In the medicine container given in any 1 paragraph of Claims 1-5,
A medicine container, wherein a pressing projection that protrudes downward is formed on the back surface of the top surface portion to the vicinity of the surface of the carrier or the solidified material placed on the bottom surface portion.

Images